Journal of Oncological Science

Aims & Scope

Journal of Oncological Science (JOS) is the official journal of Turkish Society of Medical Oncology.

The journal is an international quarterly periodical published on independent, unbiased, double-blinded and peer-review principles.

The language of publication is English.

JOS is published every 4 months (total of 3 issues per year).

With a large international editorial board of experts, JOS aims to advance clinically-relevant knowledge of cancer, and improve prevention, diagnosis and treatment of malignant disease.

It provides an integrated view of oncology across all disciplines.

The emphasis will be on publishing high quality papers rapidly and freely available to researchers worldwide.

JOS is an international multidisciplinary oncology journal, which publishes high quality original research, reviews, short communications (as letters), case reports and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology including medical oncology, pediatric oncology, radiation oncology, surgical oncology, therapeutic radiology and cancer epidemiology and prevention.

The target readership includes academic members, specialists, residents, and general practitioners working in the fields of oncology, radiation oncology, nuclear medicine, and internal medicine.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Molecular and Biological Mechanisms of Apoptosis and its Detection Techniques

  Citation: 12

  Authors: Suganya, Farhan, Krishnasamy

• Association of the Immune-Inflammation-Nutritional Parameters with Immune Checkpoint Inhibitor Outcomes in Patients with Advanced Non-Small Cell Lung Cancer

  Citation: 6

  Authors: Ömer, Polat

• Sleep Quality of Cancer Patients Receiving Systemic Treatment: A Cross-Sectional Study

  Citation: 4

  Authors: Nazlı, Mehmet Ali, Ahmet, Asiye, Filiz

• Spirituality, A Method of Coping with Depression in Cancer Patients Who Received Chemotherapy in the Southwest of Turkey (PRAYER Study)

  Citation: 3

  Authors: Özgür

• Lorlatinib-Related Vision Loss: Two Cases of Non-Small Cell Lung Cancer with Blindness

  Citation: 3

  Authors: Serdar, Özgen Ahmet, Şeyma, Şebnem, İbrahim

• Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant Chemotherapy

  Citation: 3

  Authors: Hasan Çağrı, Deniz Can, Elvin, Hakan, Feride, Serkan, Fatih, Arif, Süleyman Çağın, Hüseyin, Gözde, Şuayib, Ömer

• Vinorelbine Induced Serpentine Supravenous Hyperpigmentation

  Citation: 2

  Authors: Ahsen Duygu, Semra, Ferhat, Cumali, Atike Pınar, Ahmet

• Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

  Citation: 2

  Authors: İrfan, Aydın, Saadettin, Berna, Doğan, Mehmet, Havva, Abdurrahman, Faysal, Mehmet, Hacı Mehmet, Emin Tamer, Erdem, Meltem, Feyyaz, Ali, İlhan, Ahmet, Hüseyin, Birkan, Metin

• Gamification as a Solution for Cancer-Induced Cognitive Impairment

  Citation: 2

  Authors: Gökhan, Tarık, Önder, Ali Cem, Mustafa

• Pituitary Gland Metastasis of Breast Cancer: A Rare Case Report and Review of the Literature

  Citation: 2

  Authors: Melih